Add BrightSurf on Google Email

Researchers uncover the inside story on plant organ growth

A study by John Innes Centre researchers reveals that inner tissues play a crucial role in shaping plant organs, contradicting the widespread assumption that external layers control growth. By analyzing cell division orientation and gene editing techniques, they discovered genes affecting stem thickness in Arabidopsis.

SourceJohn Innes Centre·JournalCurrent Biology·TypeExperimental study·DateJul 8, 2026

A double agent causes surprises

Researchers at University of Würzburg discovered that inhibiting an enzyme involved in sugar metabolism makes cells more susceptible to cell death. The 'double agent' inhibitor blocks the enzyme while attacking another protective protein, leading to a paradoxical effect.

SourceUniversity of Würzburg·JournalScience Advances·TypeExperimental study·DateMay 29, 2026

Melatonin application increases effectiveness of autologous ovarian tissue transplantation, study reveals

Researchers found that melatonin increased vascularization and reduced apoptosis in ovarian grafts, improving their viability. The study used an absorbable sponge to apply melatonin to autologous ovarian tissue transplants in rats, revealing its potential as a treatment option for fertility preservation in young cancer patients.

The protein that helps cancer cells survive treatment

Researchers at Umeå University have discovered a key protein that helps cancer cells survive treatment by blocking apoptosis. The study provides a deeper understanding of how proteins interact within the cell, which could lead to new cancer therapies targeting Bcl-2 and its protective function.

SourceUmea University·JournalACS Chemical Biology·TypeExperimental study·DateApr 7, 2026

Short-circuiting pancreatic cancer

Researchers have discovered a complex regulatory circuit involving SRSF1, AURKA, and MYC that promotes aggressive pancreatic cancer progression. The circuit, which involves alternative splicing, can be targeted with an antisense oligonucleotide to reduce tumor cells' viability and trigger apoptosis.

SourceCold Spring Harbor Laboratory·JournalMolecular Cell·DateJan 8, 2026

Light-sensitive microbial protein may herald new cancer therapies

Researchers developed a new approach using the microbial protein Archaerhodopsin-3 to induce apoptosis in cancer cells, leading to significant tumor shrinkage when exposed to green light. The findings, published by Okayama University, show great potential for this light-activated molecule as a novel cancer therapy.

SourceOkayama University·JournalJournal of the American Chemical Society·TypeExperimental study·DateDec 2, 2025

Chinese Medical Journal review highlights ZBP1’s role in programmed cell death and therapeutic potential

Researchers explore ZBP1-mediated programmed cell death, its mechanisms, and therapeutic strategies for systemic diseases. The review also discusses ZBP1's involvement in various types of cell death, including apoptosis, necroptosis, pyroptosis, and ferroptosis.

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalChinese Medical Journal·TypeLiterature review·DateOct 22, 2025

New application of the anticancer drug RG7388 (Idasanutlin) in the field of anti-tick-borne viruses

Researchers have identified RG7388 as exhibiting promising antiviral activity against Severe Fever with Thrombocytopenia Syndrome Virus (SFTSV), a tick-borne pathogen with a high mortality rate. The study found that RG7388 can inhibit virus replication by enhancing cells' sensitivity to apoptotic stimulation signals.

SourceScience China Press·JournalScience Bulletin·TypeExperimental study·DateJul 11, 2025

TNIP1 knockdown induces the growth arrest and apoptosis of breast cancer cells by activating the NF-κB pathway

This study investigates TNIP1's role in regulating cell proliferation and apoptosis in breast cancer. TNIP1 knockdown was found to induce growth arrest and activate the NF-κB pathway, leading to increased apoptosis in breast cancer cells. The findings highlight TNIP1 as a crucial marker for breast cancer therapies.

SourceXia & He Publishing Inc.·JournalOncology Advances·DateMar 19, 2025

Unveiling the intricate mechanisms behind oxysterol-induced cell death

Researchers at Doshisha University reveal that 25-hydroxycholesterol causes a specific type of cell death called ferroptosis, which could contribute to various diseases. The study identifies two key mechanisms by which 25-OHC induces ferroptosis, including inhibition of cellular pathways and disruption of antioxidant systems.

SourceDoshisha University·JournalFree Radical Biology and Medicine·TypeExperimental study·DateFeb 20, 2025

Cell death and aging in cancer research review

A review of cell death and aging in cancer research reveals the significance of cellular senescence in promoting cancer growth. The study highlights the potential of various types of programmed cell death, such as necroptosis and pyroptosis, as therapeutic targets against senescent cells.

SourceOsaka Metropolitan University·JournalSeminars in Cancer Biology·TypeLiterature review·DateJan 28, 2025

Acupuncture protects brain regions in an Alzheimer’s disease mouse model by inhibiting apoptosis and reducing tau protein

This study used a senescence-accelerated prone strain 8 (SAMP8) male mice model to observe the protective effects of acupuncture on different brain regions in Alzheimer's disease. Acupuncture treatment improved learning and memory abilities, as well as depression-like behavior, by reducing apoptosis and decreasing tau protein deposition.

SourceXia & He Publishing Inc.·JournalFuture Integrative Medicine·DateJan 22, 2025

Chinese Medical Journal study reveals potential use of artificial intelligence (AI) in finding new glaucoma drugs

A study published in Chinese Medical Journal explores the use of artificial intelligence to identify potential medications for treating glaucoma. Researchers used AI models to predict the effectiveness of small-molecule compounds targeting RIPK3, a key signaling molecule involved in programmed cell death.

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalChinese Medical Journal·TypeExperimental study·DateJan 2, 2025

The longevity factor Foxo3 mediates “unfit” cell elimination to ensure healthy body construction

Researchers from Osaka University found that Foxo3 mediates erroneous cell elimination during vertebrate development, ensuring precise development and cancer prevention. The study identified a specific pathway involving Foxo3, N-cadherin, and reactive oxygen species to eliminate unfit cells with abnormal Shh activity levels.

SourceOsaka University·JournalNature Communications·TypeExperimental study·DateDec 17, 2024

Treating prostate cancer with novel platinum complex via targeting androgen receptor signaling

Researchers discovered a novel platinum complex that targets androgen receptor signaling, inhibiting cell growth and survival in prostate cancer cells. The complex, 5-H-Y, showed stronger cytotoxic effects than cisplatin with minimal toxicity, offering a promising approach to treating advanced prostate cancer.

SourceShibaura Institute of Technology·JournalInorganic Chemistry·TypeExperimental study·DateDec 16, 2024

Tumor cells suffer copper withdrawal

Researchers develop a method to remove copper from tumor cells, killing them. The nanofibers use copper-binding domains to grasp copper ions, disrupting cellular homeostasis and increasing oxidative stress.

SourceWiley·JournalAngewandte Chemie International Edition·TypeExperimental study·DateNov 20, 2024

Transcriptomic landscape analysis reveals a persistent DNA damage response in metabolic dysfunction-associated steatohepatitis post-dietary intervention

Metabolic dysfunction-associated steatohepatitis (MASLD) exhibits persistent activation of the DNA damage response (DDR) and its primary transcription factor P53 even after dietary reversal. Elevated P53 levels correlate with hepatocyte ballooning, suggesting a link between DDR signaling and MASLD recurrence.

SourceXia & He Publishing Inc.·JournalJournal of Clinical and Translational Hepatology·DateOct 24, 2024

NYU Abu Dhabi researchers discover tumor suppressor protein Par-4 triggers unique cell death pathway in cancerous cells

Researchers at NYU Abu Dhabi have discovered that the tumor suppressor protein Par-4 can cause a unique type of cell death called ferroptosis in human glioblastoma cells, while sparing healthy cells. This new understanding has the potential to inform the development of novel treatments for various hard-to-treat cancers and neurodegener...

SourceNew York University·JournalCommunications Biology·DateJul 23, 2024

Korea University identifies novel inhibitor HVH-2930 showing promise in overcoming trastuzumab resistance in HER2-positive breast cancer

A novel inhibitor HVH-2930 targeting heat shock protein 90 (HSP90) demonstrates efficacy against drug-resistant breast cancer cells. It selectively downregulates HER2 signaling, crucial for breast cancer progression, without triggering the heat shock response.

SourceKorea University College of Medicine·JournalTheranostics·TypeExperimental study·DateJun 25, 2024

Mesenchymal stem cells alleviate acute liver failure through regulating hepatocyte apoptosis and macrophage polarization

Human umbilical cord mesenchymal stem cells (hUC-MSCs) have been shown to alleviate acute liver failure by inhibiting hepatocyte apoptosis and regulating macrophage polarization. This study suggests that hUC-MSC-based cell therapy may serve as an alternative option for patients with liver failure.

SourceXia & He Publishing Inc.·JournalJournal of Clinical and Translational Hepatology·DateMay 15, 2024

Novel therapeutic bispecific antibodies for B-cell lymphoma

Researchers developed novel therapeutic bispecific antibodies targeting IgM and B-cell surface antigens, which directly inhibited cell proliferation via cell-cycle arrest and apoptosis in vitro. These findings suggest that anti-IgM/B-cell surface antigen-binding specific antibodies are promising therapeutic agents for B-cell malignancies.

SourceImpact Journals LLC·JournalOncotarget·TypeExperimental study·DateApr 16, 2024